|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.625
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.439
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.277
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.268
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.265
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.262
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.212
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.212
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.198
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.180
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.163
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.156
|
Human |
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.151
|
Human |
|
|
type b pancreatic cell development
|
GO:0003323 |
4 |
0.148
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.146
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.146
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.144
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.141
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.136
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.128
|
Human |
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
36 |
0.126
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.125
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.124
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.122
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.121
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.118
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.116
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.115
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.114
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.114
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.114
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.110
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.110
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.107
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.105
|
|
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.102
|
Human |
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.101
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.098
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.096
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.095
|
Human |
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.095
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.094
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.092
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.087
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.083
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.081
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.080
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.080
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.079
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
20 |
0.079
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.077
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.077
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.076
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.076
|
|
|
|
somatic stem cell division
|
GO:0048103 |
1 |
0.076
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.076
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.073
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.072
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.072
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.072
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.071
|
|
|
|
regulation of mitosis
|
GO:0007088 |
63 |
0.070
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.070
|
Human |
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.069
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.069
|
|
|
|
glandular epithelial cell development
|
GO:0002068 |
5 |
0.067
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.067
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.067
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.067
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.066
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.066
|
Human |
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.066
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.064
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.064
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.063
|
Human |
|
|
oogenesis
|
GO:0048477 |
2 |
0.062
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.061
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.061
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.060
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.060
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.059
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.059
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.059
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.058
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.058
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.057
|
Human |
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.057
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.056
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.056
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.056
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.055
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.055
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
6 |
0.053
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.053
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.053
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.053
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.052
|
|
|
|
type b pancreatic cell differentiation
|
GO:0003309 |
5 |
0.052
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.051
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.050
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.049
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.049
|
Human |
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.049
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.049
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.048
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.048
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.047
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.046
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.046
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.046
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.045
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.045
|
Human |
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.044
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.044
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
3 |
0.044
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.044
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.043
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.043
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.043
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.042
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.042
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.041
|
|
|
|
growth
|
GO:0040007 |
202 |
0.041
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.041
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.041
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.040
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.040
|
Human |
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.040
|
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
8 |
0.040
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.040
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.040
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.039
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.039
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.039
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.039
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.039
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
22 |
0.038
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.038
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.038
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.038
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.038
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.038
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.038
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.038
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.037
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.037
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.036
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.036
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.036
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.036
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.035
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.035
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.035
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
53 |
0.035
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.035
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.035
|
Human |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.035
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.035
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.034
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.034
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.034
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.034
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.033
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.033
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.033
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.033
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.033
|
|
|
|
positive regulation of cell cycle g2 m phase transition
|
GO:1902751 |
8 |
0.032
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.032
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.032
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.032
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.032
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.032
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.032
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.032
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.031
|
Human |
|
|
cellular senescence
|
GO:0090398 |
34 |
0.031
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.031
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.031
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.031
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.031
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.030
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.030
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.030
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.030
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.030
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.030
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.029
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.029
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.029
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.029
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.029
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.028
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.028
|
Human |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.028
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.028
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.028
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.027
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.027
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.027
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.027
|
Human |
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.027
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.027
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.026
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.026
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.026
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.026
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.026
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.026
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.025
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.025
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.025
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.025
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.025
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.025
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.025
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.025
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.024
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.024
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.024
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.024
|
Human |
|
|
signal release
|
GO:0023061 |
70 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.024
|
|
|
|
mitotic spindle elongation
|
GO:0000022 |
4 |
0.024
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.024
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.024
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.023
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.023
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.023
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.023
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.023
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.023
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.023
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.023
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.023
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.023
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.023
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.023
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.023
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.023
|
Human |
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.023
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.022
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.022
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.022
|
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
43 |
0.022
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.022
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.022
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.022
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.022
|
Human |
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.021
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.021
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.021
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.021
|
Human |
|
|
response to growth factor
|
GO:0070848 |
205 |
0.021
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.021
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.021
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.021
|
Human |
|
|
organelle localization
|
GO:0051640 |
84 |
0.021
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.021
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.020
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.020
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.020
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.020
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.020
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
38 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.020
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.020
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.020
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.020
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.020
|
Human |
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.020
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.020
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.020
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.019
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.019
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.019
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.019
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.019
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.019
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
35 |
0.019
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.019
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.019
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.019
|
Human |
|
|
regulation of binding
|
GO:0051098 |
111 |
0.019
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.019
|
|
|
|
b cell proliferation
|
GO:0042100 |
22 |
0.019
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.019
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.018
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.018
|
|
|
|
regulation of cell aging
|
GO:0090342 |
18 |
0.018
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.018
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.018
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.018
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.018
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.018
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.018
|
Human |
|
|
neuroblast division
|
GO:0055057 |
1 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.018
|
Human |
|
|
stem cell development
|
GO:0048864 |
69 |
0.018
|
|
|
|
system process
|
GO:0003008 |
349 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.018
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.018
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.018
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.018
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.018
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.018
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.017
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.017
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.017
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.017
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.017
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.017
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.017
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.017
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.017
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.017
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.017
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.017
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.017
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.016
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.016
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.016
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.016
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.016
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
54 |
0.016
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.016
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.016
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.016
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.016
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.016
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.016
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.016
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.016
|
|
|
|
aging
|
GO:0007568 |
66 |
0.016
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.015
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.015
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.015
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.015
|
|
|
|
deoxyribose phosphate metabolic process
|
GO:0019692 |
6 |
0.015
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.015
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.015
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
1 |
0.015
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.015
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.015
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.015
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.014
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.014
|
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.014
|
|
|
|
spindle elongation
|
GO:0051231 |
4 |
0.014
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.014
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.014
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.014
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.014
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
18 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.014
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.014
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.014
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.014
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.014
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.014
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.014
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.014
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.014
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.014
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
42 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.014
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.014
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.014
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.014
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.014
|
Human |
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.014
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.014
|
Human |
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.014
|
Human |
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.014
|
|
|
|
cell dedifferentiation
|
GO:0043697 |
1 |
0.014
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.013
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.013
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
65 |
0.013
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.013
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.013
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.013
|
|
|
|
v d j recombination
|
GO:0033151 |
3 |
0.013
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.013
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.013
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.013
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
19 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.013
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.013
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.013
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
59 |
0.013
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.013
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.013
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.013
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.013
|
Human |
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.013
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.013
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.013
|
|
|
|
response to camp
|
GO:0051591 |
25 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.013
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.013
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.013
|
Human |
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.012
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.012
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.012
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.012
|
Human |
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.012
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.012
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.012
|
|
|
|
negative regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000059 |
3 |
0.012
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.012
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.012
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.012
|
|
|
|
t cell differentiation
|
GO:0030217 |
29 |
0.012
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.012
|
|
|
|
protein homotetramerization
|
GO:0051289 |
28 |
0.012
|
|
|
|
dedifferentiation
|
GO:0043696 |
1 |
0.012
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.012
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.012
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.012
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.012
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
25 |
0.012
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.012
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.012
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.012
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.012
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.012
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.012
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.012
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.012
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.012
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.011
|
|
|
|
lung cell differentiation
|
GO:0060479 |
1 |
0.011
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.011
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.011
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.011
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.011
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.011
|
|
|
|
neural crest cell migration
|
GO:0001755 |
2 |
0.011
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.011
|
|
|
|
negative regulation of proteasomal protein catabolic process
|
GO:1901799 |
32 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.011
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.011
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.011
|
|
